Kamata Mineto, Sebastian Roby, McConnell Patrick I, Gomez Daniel, Naguib Aymen, Tobias Joseph D
Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital.
Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital; Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine.
Int Med Case Rep J. 2017 Feb 14;10:55-63. doi: 10.2147/IMCRJ.S118250. eCollection 2017.
Heparin-induced thrombocytopenia (HIT) can cause life-threatening complications following the administration of heparin. Discontinuation of all sources of heparin exposure and the use of alternative agents for anticoagulation are necessary when HIT is suspected or diagnosed. We present the successful use of bivalirudin anticoagulation in an adolescent patient during cardiopulmonary bypass who underwent both placement of a left ventricular assist device and subsequent heart transplantation within a 36-hour period. The pathophysiology and diagnosis of HIT are reviewed, previous reports of the use of direct thrombin inhibitors for cardiac surgery are presented, and potential dosing regimens for bivalirudin are discussed.
肝素诱导的血小板减少症(HIT)在使用肝素后可导致危及生命的并发症。当怀疑或诊断为HIT时,必须停用所有肝素暴露源并使用替代抗凝剂。我们介绍了比伐芦定抗凝在一名青少年患者体外循环期间的成功应用,该患者在36小时内接受了左心室辅助装置植入及随后的心脏移植。本文回顾了HIT的病理生理学和诊断方法,介绍了以往关于直接凝血酶抑制剂用于心脏手术的报道,并讨论了比伐芦定的潜在给药方案。